ABSTRACT
For decades, cardiovascular diseases (CVDs) have been the leading cause of death in developed nations. The diseases are disorders related to heart and blood vasculature [1]. Despite significant advances in pharmacological, interventional, and surgical therapy, CVDs account for about 36% of deaths in the United States and Europe, especially due to myocardial infarction and heart failure [2, 3].
